Skip to main content
Erschienen in: Annals of Surgical Oncology 7/2008

01.07.2008 | Healthcare Policy and Outcomes

Health-Related Quality of Life Outcomes in Disease-Free Survivors of Mid-Low Rectal Cancer After Curative Surgery

verfasst von: Salvatore Pucciarelli, MD, Paola Del Bianco, MSc, Paola Toppan, MD, Samantha Serpentini, MSc, Fabio Efficace, MSc, Lara Maria Pasetto, MD, Maria Luisa Friso, MD, Gian Luca De Salvo, MD, Donato Nitti, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 7/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

The main objective of this study was to investigate health-related quality of life (HRQOL) in terms of symptoms and functional outcomes in disease-free survivors of rectal cancer.

Methods

Consecutive patients (n = 117) who underwent curative surgery for rectal cancer with a minimum of 2 years’ follow-up and whose disease had not recurred were asked to complete the European Organization for Research and Treatment of Cancer QLQ-C30 and its colorectal cancer module (QLQ-CR38). Long-term HRQOL outcomes were compared with reference data from the general population. Relevant clinical data including type of surgery, stage of disease, type of treatment, and early and late complications were collected. Univariate and multivariate regression analyses were performed to investigate associations among covariates.

Results

HRQOL functional aspects were similar with that of an age- and sex-matched general population. Although clinically meaningful better outcomes favoring our patients were found for the global health status/HRQOL and the pain scales, constipation was worse in rectal cancer survivors than the general population. Multivariate analysis found that worse physical functioning was associated with increasing age (P < .001), female sex (P < .01), presence of stoma (P < .05), and occurrence of late major complications (P < .05). Worse body image was associated with the presence of stoma (P < .001) and chemoradiotherapy (P < .05).

Conclusion

Overall, patients with rectal cancer recover well in the long run, with HRQOL levels comparable to that of the general population. HRQOL outcomes provide valuable data that may be used to improve information disclosure to patients.
Literatur
1.
Zurück zum Zitat Langenhoff BS, Krabbe PFM, Wobbes T, et al. Quality of life as an outcome measure in surgical oncology. Br J Surg 2001; 88:643–52PubMedCrossRef Langenhoff BS, Krabbe PFM, Wobbes T, et al. Quality of life as an outcome measure in surgical oncology. Br J Surg 2001; 88:643–52PubMedCrossRef
2.
Zurück zum Zitat Blazeby JM, Avery K, Sprangers M, et al. Health-related quality of life measurement in randomized clinical trials in surgical oncology. J Clin Oncol 2006; 24:3178–86PubMedCrossRef Blazeby JM, Avery K, Sprangers M, et al. Health-related quality of life measurement in randomized clinical trials in surgical oncology. J Clin Oncol 2006; 24:3178–86PubMedCrossRef
3.
Zurück zum Zitat Gotay CC, Muraoka M. Quality of life in long-term survivors of adult-onset cancers. J Natl Cancer Inst 1998; 90:656–67PubMedCrossRef Gotay CC, Muraoka M. Quality of life in long-term survivors of adult-onset cancers. J Natl Cancer Inst 1998; 90:656–67PubMedCrossRef
4.
Zurück zum Zitat Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345:638–46PubMedCrossRef Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345:638–46PubMedCrossRef
5.
Zurück zum Zitat Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351:1731–40PubMedCrossRef Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351:1731–40PubMedCrossRef
6.
Zurück zum Zitat Camilleri-Brennan J, Steele JC. Quality of life after treatment for rectal cancer. Br J Surg 1998; 85:1036–43PubMedCrossRef Camilleri-Brennan J, Steele JC. Quality of life after treatment for rectal cancer. Br J Surg 1998; 85:1036–43PubMedCrossRef
7.
Zurück zum Zitat Temple LK, Bacik J, Savatta SG, et al. The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer. Dis Colon Rectum 2005; 48:1353–64PubMedCrossRef Temple LK, Bacik J, Savatta SG, et al. The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer. Dis Colon Rectum 2005; 48:1353–64PubMedCrossRef
8.
Zurück zum Zitat Grumann MM, Noack EM, Hoffmann IA, et al. Comparison of quality of life in patients undergoing abdominoperineal extirpation or anterior resection for rectal cancer. Ann Surg 2001; 233:149–56PubMedCrossRef Grumann MM, Noack EM, Hoffmann IA, et al. Comparison of quality of life in patients undergoing abdominoperineal extirpation or anterior resection for rectal cancer. Ann Surg 2001; 233:149–56PubMedCrossRef
9.
Zurück zum Zitat Hamashima C. HRQOL of postoperative rectal cancer. Long-term quality of life of postoperative rectal cancer patients. J Gastroenterol Hepatol 2002; 17:571–6PubMedCrossRef Hamashima C. HRQOL of postoperative rectal cancer. Long-term quality of life of postoperative rectal cancer patients. J Gastroenterol Hepatol 2002; 17:571–6PubMedCrossRef
10.
Zurück zum Zitat Rauch P, Miny J, Conroy T, et al. Quality of life among disease-free survivors of rectal cancer. J Clin Oncol 2004; 22:354–60PubMedCrossRef Rauch P, Miny J, Conroy T, et al. Quality of life among disease-free survivors of rectal cancer. J Clin Oncol 2004; 22:354–60PubMedCrossRef
11.
Zurück zum Zitat Engel J, Kerr J, Schleisinger-Racib A, et al. Quality of life in rectal cancer patients: a four-year prospective study. Ann Surg 2003; 238:203–13PubMed Engel J, Kerr J, Schleisinger-Racib A, et al. Quality of life in rectal cancer patients: a four-year prospective study. Ann Surg 2003; 238:203–13PubMed
12.
Zurück zum Zitat Schmidt CE, Bestmann B, Kuchler T, et al. Impact of age on quality of life in patients with rectal cancer. World J Surg 2005; 29:190–7PubMedCrossRef Schmidt CE, Bestmann B, Kuchler T, et al. Impact of age on quality of life in patients with rectal cancer. World J Surg 2005; 29:190–7PubMedCrossRef
13.
Zurück zum Zitat AJCC American Joint Committee on Cancer. Fleming DI, Cooper SJ, Henson ED, et al. (eds). AJCC cancer staging manual. 5th edition. Philadelphia: Lippincott-Raven, 1997:83–90 AJCC American Joint Committee on Cancer. Fleming DI, Cooper SJ, Henson ED, et al. (eds). AJCC cancer staging manual. 5th edition. Philadelphia: Lippincott-Raven, 1997:83–90
14.
Zurück zum Zitat Urso E, Serpentini S, Pucciarelli S, et al. Complications, functional outcome and quality of life after intensive preoperative chemoradiotherapy for rectal cancer. Eur J Surg Oncol 2006; 32:1201–8PubMedCrossRef Urso E, Serpentini S, Pucciarelli S, et al. Complications, functional outcome and quality of life after intensive preoperative chemoradiotherapy for rectal cancer. Eur J Surg Oncol 2006; 32:1201–8PubMedCrossRef
15.
Zurück zum Zitat Pucciarelli S, Toppan P, Friso ML, et al. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome. Dis Colon Rectum 2004; 47:1798–807PubMedCrossRef Pucciarelli S, Toppan P, Friso ML, et al. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome. Dis Colon Rectum 2004; 47:1798–807PubMedCrossRef
16.
Zurück zum Zitat Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85:365–76PubMedCrossRef Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85:365–76PubMedCrossRef
17.
Zurück zum Zitat Sprangers MAG, te Velde A, Aaronson NK. The construction and testing of the EORTC colorectal cancer-specific Quality of Life Questionnaire Module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life. Eur J Cancer 1999; 35:238–47PubMedCrossRef Sprangers MAG, te Velde A, Aaronson NK. The construction and testing of the EORTC colorectal cancer-specific Quality of Life Questionnaire Module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life. Eur J Cancer 1999; 35:238–47PubMedCrossRef
18.
Zurück zum Zitat Cull A, Sprangers M, Bjordal K, et al. EORTC quality of life group translation procedure. 2nd edition. Brussels: EORTC Publications, 2002 Cull A, Sprangers M, Bjordal K, et al. EORTC quality of life group translation procedure. 2nd edition. Brussels: EORTC Publications, 2002
19.
Zurück zum Zitat Fayers P, Aaronson N, Bjordal K, et al. EORTC QLQ-C30 scoring manual. 2nd edition. Brussels, Belgium: European Organization for Research and Treatment of Cancer, 1999 Fayers P, Aaronson N, Bjordal K, et al. EORTC QLQ-C30 scoring manual. 2nd edition. Brussels, Belgium: European Organization for Research and Treatment of Cancer, 1999
20.
Zurück zum Zitat Schwarz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 2001; 37:1345–51PubMedCrossRef Schwarz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 2001; 37:1345–51PubMedCrossRef
21.
Zurück zum Zitat Hjermstad MJ, Fayers PM, Bjordal K, et al. Using reference data on quality of life—the importance of adjusting for age and gender, exemplified by the EORTC QLQ-C30 (+3). Eur J Cancer 1998; 34:1381–9PubMedCrossRef Hjermstad MJ, Fayers PM, Bjordal K, et al. Using reference data on quality of life—the importance of adjusting for age and gender, exemplified by the EORTC QLQ-C30 (+3). Eur J Cancer 1998; 34:1381–9PubMedCrossRef
22.
Zurück zum Zitat Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998; 16:139–44PubMed Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998; 16:139–44PubMed
23.
Zurück zum Zitat Neumann HB, Schrag D, Cabral C, et al. Can differences in bowel function after surgery for rectal cancer be identified by the European Organization for Research and Treatment of Cancer quality of life instruments? Ann Surg Oncol 2007; 14:1735–43CrossRef Neumann HB, Schrag D, Cabral C, et al. Can differences in bowel function after surgery for rectal cancer be identified by the European Organization for Research and Treatment of Cancer quality of life instruments? Ann Surg Oncol 2007; 14:1735–43CrossRef
24.
Zurück zum Zitat Arndt V, Merx H, Stegmaier C, et al. Restrictions in quality of life in colorectal cancer patients over three years after diagnosis: a population based study. Eur J Cancer 2006; 42:1848–57PubMedCrossRef Arndt V, Merx H, Stegmaier C, et al. Restrictions in quality of life in colorectal cancer patients over three years after diagnosis: a population based study. Eur J Cancer 2006; 42:1848–57PubMedCrossRef
25.
Zurück zum Zitat Arndt V, Merx H, Stegmaier C, et al. Quality of life in patients with colorectal cancer 1 year after diagnosis compared with the general population: a population-based study. J Clin Oncol 2004; 22:4829–36PubMedCrossRef Arndt V, Merx H, Stegmaier C, et al. Quality of life in patients with colorectal cancer 1 year after diagnosis compared with the general population: a population-based study. J Clin Oncol 2004; 22:4829–36PubMedCrossRef
26.
Zurück zum Zitat Sprangers MAG, Schwartz CE. the challenge of response shift for quality-of-life-based clinical oncology research. Ann Oncol 1999; 10:747–9PubMedCrossRef Sprangers MAG, Schwartz CE. the challenge of response shift for quality-of-life-based clinical oncology research. Ann Oncol 1999; 10:747–9PubMedCrossRef
27.
Zurück zum Zitat Guren MG, Dueland S, Skovlund E, et al. Quality of life during radiotherapy for rectal cancer. Eur J Cancer 2003; 39:587–94PubMedCrossRef Guren MG, Dueland S, Skovlund E, et al. Quality of life during radiotherapy for rectal cancer. Eur J Cancer 2003; 39:587–94PubMedCrossRef
28.
Zurück zum Zitat Hendren SK, O’Connor BI, Liu M, et al. Prevalence of male and famale sexual dysfunction is high following surgery for rectal cancer. Ann Surg 2005; 242:212–23PubMedCrossRef Hendren SK, O’Connor BI, Liu M, et al. Prevalence of male and famale sexual dysfunction is high following surgery for rectal cancer. Ann Surg 2005; 242:212–23PubMedCrossRef
29.
Zurück zum Zitat Marijnen CAM, van de Velde CJH, Putter H, et al. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 2005; 23:1847–58PubMedCrossRef Marijnen CAM, van de Velde CJH, Putter H, et al. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 2005; 23:1847–58PubMedCrossRef
30.
Zurück zum Zitat Guren MG, Eriksen MT, Wiig JN, et al. on behalf of the Norwegian Rectal Cancer Group. Quality of life and functional outcome following anterior or abdominoperineal resection for rectal cancer. Eur J Surg Oncol 2005; 31:735–42PubMedCrossRef Guren MG, Eriksen MT, Wiig JN, et al. on behalf of the Norwegian Rectal Cancer Group. Quality of life and functional outcome following anterior or abdominoperineal resection for rectal cancer. Eur J Surg Oncol 2005; 31:735–42PubMedCrossRef
31.
Zurück zum Zitat Hagedoorn M, Sneeuw KCA, Aaronson N. Changes in physical functioning and quality of life in patients with cancer: response shift and relative evaluation of one’s condition. J Clin Epidemiol 2002; 55:176–83PubMedCrossRef Hagedoorn M, Sneeuw KCA, Aaronson N. Changes in physical functioning and quality of life in patients with cancer: response shift and relative evaluation of one’s condition. J Clin Epidemiol 2002; 55:176–83PubMedCrossRef
32.
Zurück zum Zitat Bernhard J, Hürny C, Maibach R. Quality of life as subjective experience: reframing of perception in patients with colon cncer undergoing radical resection with or without adjuvant chemotherapy. Swiss Group for Clinical Cancer Research (SAKK). Ann Oncol 1999; 10:775–82PubMedCrossRef Bernhard J, Hürny C, Maibach R. Quality of life as subjective experience: reframing of perception in patients with colon cncer undergoing radical resection with or without adjuvant chemotherapy. Swiss Group for Clinical Cancer Research (SAKK). Ann Oncol 1999; 10:775–82PubMedCrossRef
33.
Zurück zum Zitat Sprangers MA, Schwartz CE. Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med 1999; 48:1507–15PubMedCrossRef Sprangers MA, Schwartz CE. Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med 1999; 48:1507–15PubMedCrossRef
34.
Zurück zum Zitat Allal AB, Gervaz P, Gertsch P, et al. Assessment of quality of life in patients with rectal cancer treated by preoperative radiotherapy: a longitudinal prospective study. Int J Radiat Oncol Biol Phys 2005; 61:1129–35PubMed Allal AB, Gervaz P, Gertsch P, et al. Assessment of quality of life in patients with rectal cancer treated by preoperative radiotherapy: a longitudinal prospective study. Int J Radiat Oncol Biol Phys 2005; 61:1129–35PubMed
35.
Zurück zum Zitat Apolone G, Mosconi P. The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol 1998; 51:1025–36PubMedCrossRef Apolone G, Mosconi P. The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol 1998; 51:1025–36PubMedCrossRef
36.
Zurück zum Zitat Apolone G, Filiberti A, Cifani S, et al. Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 health survey in a cohort of Italian long-survival cancer patients. Ann Oncol 1998; 9:549–57PubMedCrossRef Apolone G, Filiberti A, Cifani S, et al. Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 health survey in a cohort of Italian long-survival cancer patients. Ann Oncol 1998; 9:549–57PubMedCrossRef
Metadaten
Titel
Health-Related Quality of Life Outcomes in Disease-Free Survivors of Mid-Low Rectal Cancer After Curative Surgery
verfasst von
Salvatore Pucciarelli, MD
Paola Del Bianco, MSc
Paola Toppan, MD
Samantha Serpentini, MSc
Fabio Efficace, MSc
Lara Maria Pasetto, MD
Maria Luisa Friso, MD
Gian Luca De Salvo, MD
Donato Nitti, MD
Publikationsdatum
01.07.2008
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 7/2008
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-008-9923-0

Weitere Artikel der Ausgabe 7/2008

Annals of Surgical Oncology 7/2008 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.